Aflac insider sale by Japan Post draws attention, shares hold near recent highs
22.06.2026 - 19:09:52 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-22, 19:05.
Aflac (US0010551028) has come into focus after major shareholder Japan Post Holdings disclosed the sale of 26,300 shares, worth about $3.07 million, in a recent SEC Form 4 filing. The New York-listed insurer’s shares continue to trade near recent highs on the NYSE, supported by robust first-quarter revenue figures.
Details of the Japan Post share sale
Japan Post Holdings Co., Ltd., a 10 percent owner of Aflac, reported selling a total of 26,300 Aflac shares on 17 June 2026, according to the Form 4 disclosure summarised by StockTitan and Investing.com. The StockTitan summary of the Form 4 filing states that the transactions amounted to roughly $3.07 million.
The trades were executed in two blocks: 25,382 shares at a weighted average price of $116.59 and 918 shares at a weighted average of $117.34, within intraday ranges between about $116.20 and $117.51 per share, according to an Investing.com report on the filing. The Investing.com article on the Japan Post sale After the sale, Japan Post still indirectly holds more than 50.9 million Aflac shares, underlining its continued role as a core shareholder.
How Aflac shares and earnings look
Aflac shares recently traded around the mid-110 dollar range, with MarketBeat quoting a level near $117.50 on the NYSE and describing a market capitalization of roughly $58.8 billion, a price-earnings ratio of 13.1 and a beta of 0.61. MarketBeat’s coverage of the insider sale and valuation metrics The same source notes that the 50-day moving average stands near $115.22, above the 200-day average of about $112.21.
Operationally, Aflac reported first-quarter 2026 revenue of $4.35 billion, beating forecasts of $4.18 billion, while earnings per share came in at $1.75, slightly below the $1.80 consensus, according to Investing.com’s recap of the results and subsequent shareholder meeting. The same Investing.com report also summarizes Aflac’s Q1 2026 numbers and AGM decisions Revenue was up 27.9 percent year-on-year in the quarter, while last year’s comparable earnings per share stood at $1.66, underscoring a solid underlying growth trend despite the small EPS shortfall versus expectations.
Background and price data on Aflac
All further ad hoc reports, chart data and corporate disclosures on the Aflac shares can be found in the dedicated topic section and on the company’s investor-relations pages.
What the company sells
Aflac generates most of its revenue by offering supplemental health and life insurance products, with a strong presence in the United States and Japan. The group’s portfolio includes cancer policies, hospital indemnity coverage, critical illness insurance and accident plans that are typically sold through employers and independent agents.
Where the stock trades today
The Aflac shares (US0010551028) most recently traded on the NYSE at around $117.50, according to MarketBeat data as of 2026-06-22, 11:42 Eastern Time, reflecting a market capitalization close to $58.8 billion in U.S. dollars.
Key data on the Aflac shares
- Company: Aflac Incorporated
- ISIN: US0010551028
- WKN: 853081
- Ticker: AFL
- Trading venue: NYSE
- Price (as of 2026-06-22, 11:42): 117.50 USD
- Market cap: 58.79 billion USD (as of 2026-06-22)
- Sector / industry: Financials / Life & Health Insurance
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial guidance. Investors should conduct their own research or consult a qualified financial advisor before making investment decisions.
